Both the breast cancer and melanoma studies have focused on the impact of CD81+CD63+EVs in inhibiting lung metastasis and it remains to be seen if this impact of CD81+CD63+EVs is restricted to the lung or if it also impacts metastasis to the other organs. This evidence concerns the gene CD81 and breast cancer.